Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -321,545 | -261,281 | -206,470 | -136,061 | -111,399 |
| Depreciation Amortization | 40,745 | 31,464 | 20,225 | 9,880 | 32,792 |
| Accounts receivable | -6,001 | -4,017 | -3,286 | -1,547 | -11,264 |
| Accounts payable and accrued liabilities | -17,563 | -18,573 | -15,641 | -24,841 | 24,763 |
| Other Working Capital | -63,020 | -70,421 | -63,683 | -2,946 | -25,475 |
| Other Operating Activity | 129,909 | 121,073 | 109,607 | 36,510 | -189,438 |
| Operating Cash Flow | $-237,475 | $-201,755 | $-159,248 | $-119,005 | $-280,021 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 200,577 | 271,285 | 216,967 | 111,364 | -109,367 |
| PPE Investments | N/A | -82 | -82 | N/A | N/A |
| Purchase Sale Intangibles | -36,212 | -26,569 | -18,377 | -6,466 | -41,591 |
| Other Investing Activity | -101,252 | -91,569 | -83,377 | -6,466 | 165,143 |
| Investing Cash Flow | $99,325 | $179,634 | $133,508 | $104,898 | $55,776 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 139,190 | 571 | 0 | 0 | 219,068 |
| Other Financing Activity | 232 | -268 | 257 | -525 | -316 |
| Financing Cash Flow | $139,422 | $303 | $257 | $-525 | $218,752 |
| Exchange Rate Effect | -913 | 51 | -402 | -293 | 1,981 |
| Beginning Cash Position | 58,176 | 58,176 | 58,176 | 58,176 | 61,688 |
| End Cash Position | 58,535 | 36,409 | 32,291 | 43,251 | 58,176 |
| Net Cash Flow | $359 | $-21,767 | $-25,885 | $-14,925 | $-3,512 |
| Free Cash Flow | |||||
| Operating Cash Flow | -237,475 | -201,755 | -159,248 | -119,005 | -280,021 |
| Capital Expenditure | N/A | -82 | -82 | N/A | N/A |
| Free Cash Flow | -237,475 | -201,837 | -159,330 | -119,005 | -280,021 |